SEARCH

SEARCH BY CITATION

References

  • 1
    Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Geneva, Switzerland: WHO Press, 2008.
  • 2
    International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 74957.
  • 3
    Palumbo A, Bringhen S, Ludwig H, et al. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood 2011; 118: 451929.
  • 4
    National Cancer Institute. Surveillance Epidemiology and End Results. SEER Stat Fact Sheets: Myeloma. 2011. Available at http://seer.cancer.gov/statfacts/html/mulmy.html. Accessed on 06 March 2012).
  • 5
    Alexander DD, Mink PJ, Adami HO, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 2007; 120 ( Suppl 12): 4061.
  • 6
    Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009; 113: 541217.
  • 7
    Kyle RA, Rajkumar SV. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 2007; 20: 63764.
  • 8
    Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res 2011; 183: 2535.
  • 9
    World Health Organization. Global Health Observatory. 2012. Available at http://www.who.int/gho/tobacco/en/. Accessed on 06 March 2012).
  • 10
    Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 276578.
  • 11
    Huncharek M, Haddock KS, Reid R, et al. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010; 100: 693701.
  • 12
    DeRoo LA, Cummings P, Mueller BA. Smoking before the first pregnancy and the risk of breast cancer: a meta-analysis. Am J Epidemiol 2011; 174: 390402.
  • 13
    Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med 2002; 252: 20624.
  • 14
    Jordan SJ, Whiteman DC, Purdie DM, et al. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006; 103: 11229.
  • 15
    Castillo JJ, Dalia S, Shum H. Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma. J Clin Oncol 2011; 29: 39006.
  • 16
    Sergentanis TN, Kanavidis P, Michelakos T, et al. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. Eur J Cancer Prev, 2012 Jul 1. [Epub ahead of print].
  • 17
    Castillo JJ, Dalia S. Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: a meta-analysis of 24 observational studies. Leuk Lymphoma 2012; 53: 19119.
  • 18
    Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 2008; 68: 1907.
  • 19
    Rasmussen T, Jensen L, Johnsen HE. The clonal hierachy in multiple myeloma. Acta Oncol 2000; 39: 76570.
  • 20
    Castillo JJ, Dhami PK, Curry S, et al. No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. Am J Hematol 2012; 87: 72931.
  • 21
    Mullan RJ, Flynn DN, Carlberg B, et al. Systematic reviewers commonly contact study authors but do so with limited rigor. J Clin Epidemiol 2009; 62: 13842.
  • 22
    Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 200812.
  • 23
    Hamling J, Lee P, Weitkunat R, et al. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008; 27: 95470.
  • 24
    Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org. Accessed on 06 March 2012.
  • 25
    Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 62934.
  • 26
    Mangiapane S, Blettner M, Schlattmann P. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf 2008; 17: 11524.
  • 27
    Sergentanis TN, Zagouri F, Zografos GC. Is antibiotic use a risk factor for breast cancer? A meta-analysis. Pharmacoepidemiol Drug Saf 2010; 19: 11017.
  • 28
    Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993; 4: 21828.
  • 29
    Il'yasova D, Hertz-Picciotto I, Peters U, et al. Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control 2005; 16: 3838.
  • 30
    Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003; 22: 2693710.
  • 31
    Schnatter AR, Armstrong TW, Nicolich MJ, et al. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med 1996; 53: 77381.
  • 32
    Nanni O, Falcini F, Buiatti E, et al. Multiple myeloma and work in agriculture: results of a case–control study in Forli, Italy. Cancer Causes Control 1998; 9: 27783.
  • 33
    Blair CK, Cerhan JR, Folsom AR, et al. Anthropometric characteristics and risk of multiple myeloma. Epidemiology 2005; 16: 6914.
  • 34
    Casey R, Piazzon-Fevre K, Raverdy N, et al. Case–control study of lymphoid neoplasm in three French areas: description, alcohol and tobacco consumption. Eur J Cancer Prev 2007; 16: 14250.
  • 35
    Ellison-Loschmann L, Benavente Y, Douwes J, et al. Immunoglobulin E levels and risk of lymphoma in a case–control study in Spain. Cancer Epidemiol Biomarkers Prev 2007; 16: 14928.
  • 36
    Klatsky AL, Li Y, Baer D, et al. Alcohol consumption and risk of hematologic malignancies. Ann Epidemiol 2009; 19: 74653.
  • 37
    Kokouva M, Bitsolas N, Hadjigeorgiou GM, et al. Pesticide exposure and lymphohaematopoietic cancers: a case–control study in an agricultural region (Larissa, Thessaly, Greece). BMC Public Health 2011; 11: 5.
  • 38
    Walter RB, Milano F, Brasky TM, et al. Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study. J Clin Oncol 2011; 29: 242431.
  • 39
    Miligi L, Seniori Costantini A, Crosignani P, et al. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 1999; 36: 609.
  • 40
    Stagnaro E, Ramazzotti V, Crosignani P, et al. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001; 12: 32534.
  • 41
    Schwartzbaum J, Ahlbom A, Feychting M. Berkson's bias reviewed. Eur J Epidemiol 2003; 18: 110912.
  • 42
    Geng Y, Savage SM, Johnson LJ, et al. Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol Appl Pharmacol 1995; 135: 26878.
  • 43
    Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res 2008; 57: 497503.
  • 44
    Fusby JS, Kassmeier MD, Palmer VL, et al. Cigarette smoke-induced effects on bone marrow B-cell subsets and CD4+:CD8+ T-cell ratios are reversed by smoking cessation: influence of bone mass on immune cell response to and recovery from smoke exposure. Inhal Toxicol 2010; 22: 78596.
  • 45
    Pyatt D, Natelson E, Golden R. Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies? Regul Toxicol Pharmacol 2008; 51: 11933.
  • 46
    Galvan N, Page TJ, Czuprynski CJ, et al. Benzo(a)pyrene and 7,12-dimethylbenz(a)anthrecene differentially affect bone marrow cells of the lymphoid and myeloid lineages. Toxicol Appl Pharmacol 2006; 213: 10516.
  • 47
    Monnereau A, Orsi L, Troussard X, et al. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case–control study. Cancer Causes Control 2008; 19: 114760.
  • 48
    Xu W, Trepel J, Neckers L. Ras, ROS and proteotoxic stress: a delicate balance. Cancer Cell 2011; 20: 2812.